Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 18 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
June 2, 2026 BMRN A 7,490 · · 21,040 Direct +55.28% Acquired (price as of 2026-10-02)
May 8, 2026 CRL A 1,438 $177.62 $255,418 2,384 Direct +152.01% Acquired 63.4% (price as of 2026-10-02)
June 2, 2025 CRL A 2,082 $135.04 $281,153 2,082 Direct · Acquired 114.9% (price as of 2026-10-02)
June 2, 2025 CRL A 946 $135.04 $127,748 946 Direct · Acquired 114.9% (price as of 2026-10-02)
May 20, 2025 BMRN A 6,650 · · 13,550 Direct +96.38% Acquired (price as of 2026-10-02)
May 21, 2024 BMRN A 4,720 · · 6,900 Direct +216.51% Acquired (price as of 2026-10-02)
Dec. 27, 2023 BMRN A 2,180 · · 2,180 Direct · Acquired (price as of 2026-10-02)
June 5, 2020 AKBA A 13,700 · · 31,143 Direct +78.54% Acquired (price as of 2026-10-02)
June 5, 2020 AKBA A 20,100 · · 20,100 Direct · Acquired (price as of 2026-10-02)
June 6, 2019 AKBA A 13,700 · · 17,443 Direct +366.02% Acquired (price as of 2026-10-02)
June 6, 2019 AKBA A 20,100 · · 20,100 Direct · Acquired (price as of 2026-10-02)
Dec. 12, 2018 AKBA A 25,000 · · 25,000 Direct · Acquired (price as of 2026-10-02)
Dec. 12, 2018 AKBA A 11,229 · · 11,229 Direct · Acquired (price as of 2026-10-02)
Dec. 12, 2018 AKBA A 18,716 · · 18,716 Direct · Acquired (price as of 2026-10-02)
Dec. 12, 2018 AKBA A 3,743 · · 3,743 Direct · Acquired (price as of 2026-10-02)
May 11, 2016 FATE A 25,000 · · 25,000 Direct · Acquired (price as of 2026-10-02)
May 13, 2015 FATE A 10,000 · · 10,000 Direct · Acquired (price as of 2026-10-02)
June 6, 2014 FATE A 10,000 · · 10,000 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 2, 2025 CRL Stock Options (Right to Buy) Common Stock (2,082) $135.04 June 2, 2035 2,082 Acquired
June 5, 2020 AKBA Stock Option (Right to buy) Common Stock (20,100) $11.96 June 5, 2030 20,100 Acquired
June 6, 2019 AKBA Stock Option (Right to buy) Common Stock (20,100) $4.23 June 6, 2029 20,100 Acquired
Dec. 12, 2018 AKBA Stock Option (Right to buy) Common Stock (25,000) $8.94 Dec. 12, 2028 25,000 Acquired
Dec. 12, 2018 AKBA Stock Option (Right to buy) Common Stock (11,229) $10.05 June 30, 2028 11,229 Acquired
Dec. 12, 2018 AKBA Stock Option (Right to buy) Common Stock (18,716) $19.56 Sept. 11, 2027 18,716 Acquired
May 11, 2016 FATE Stock Option (right to buy) Common Stock (25,000) $1.69 May 10, 2026 25,000 Acquired
May 13, 2015 FATE Stock Option (right to buy) Common Stock (10,000) $7.08 May 12, 2025 10,000 Acquired
June 6, 2014 FATE Stock Option (right to buy) Common Stock (10,000) $6.71 June 5, 2024 10,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 29, 2025 CRL Common Stock 0 Direct
Sept. 30, 2013 FATE Stock Option (right to buy)→ Common Stock (30,769) 30,769 Direct